Earnings · China A-shares
Harbin Pharmaceutical Group Co., Ltd. Class A (600664) earnings
Harbin Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +82.66% year on year, +83.18% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -3.82% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +82.66%
- Excl. one-offs YoY
- +83.18%
- Net profit QoQ
- -23.79%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.64% | — |
| 3 days | -3.82% | — |
| 7 days | +4.36% | — |
| 14 days | -6.00% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 1 of 6 reports (average -1.84%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥600.23M | +82.66% | +83.18% | +2.75% | 0.24 | 10.02% | -3.82% | — | — |
| 2026 interim report | 2026-08-26 | ¥410.32M | +57.99% | +45.39% | +2.10% | 0.16 | 6.96% | +9.62% | -24.97% | -17.98% |
| 2026 Q1 report | 2026-04-23 | ¥161.13M | -24.33% | -24.75% | +0.02% | 0.06 | 2.79% | -6.62% | -20.87% | -19.31% |
| 2025 annual report | 2026-04-23 | ¥361.60M | -42.50% | -47.49% | -1.31% | 0.14 | 6.55% | -6.62% | -20.87% | -19.31% |
| 2025 Q3 report | 2025-10-25 | ¥328.59M | -35.35% | -38.56% | -1.92% | 0.13 | 5.96% | -1.62% | +1.08% | +1.30% |
| 2025 interim report | 2025-08-23 | ¥259.71M | -24.37% | -21.71% | -0.21% | 0.10 | 4.74% | -6.44% | -10.89% | -15.76% |
| 2025 Q1 report | 2025-04-26 | ¥212.93M | +20.48% | +28.06% | +0.78% | 0.08 | 3.90% | -2.17% | +6.52% | +3.28% |
| 2024 annual report | 2025-04-26 | ¥628.85M | +59.10% | +80.08% | +4.65% | 0.25 | 12.48% | -2.17% | +6.52% | +3.28% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 600664 · Stock news: 600664
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.